These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9193008)

  • 1. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
    Nguyen KN; Aursnes I; Kjekshus J
    Am J Cardiol; 1997 Jan; 79(2):115-9. PubMed ID: 9193008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
    Swedberg K; Held P; Kjekshus J; Rasmussen K; Rydén L; Wedel H
    N Engl J Med; 1992 Sep; 327(10):678-84. PubMed ID: 1495520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects on cardiac output and peripheral resistance in patients treated with enalapril after acute myocardial infarction. CONSENSUS II Multi-Echo Study Group. Cooperative New Scandinavian Enalapril Survival Study.
    Edner M; Caidahl K; Bonarjee VV; Nilsen DW; Carstensen S; Berning J
    Cardiology; 1998 May; 89(4):291-6. PubMed ID: 9643277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
    Nawarskas JJ; Townsend RR; Cirigliano MD; Spinler SA
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):784-9. PubMed ID: 10480471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
    Leor J; Reicher-Reiss H; Goldbourt U; Boyko V; Gottlieb S; Battler A; Behar S
    J Am Coll Cardiol; 1999 Jun; 33(7):1920-5. PubMed ID: 10362194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.
    Latini R; Tognoni G; Maggioni AP; Baigent C; Braunwald E; Chen ZM; Collins R; Flather M; Franzosi MG; Kjekshus J; Køber L; Liu LS; Peto R; Pfeffer M; Pizzetti F; Santoro E; Sleight P; Swedberg K; Tavazzi L; Wang W; Yusuf S
    J Am Coll Cardiol; 2000 Jun; 35(7):1801-7. PubMed ID: 10841227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
    Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enalapril initiated early after acute myocardial infarction on heart failure parameters, with reference to clinical class and echocardiographic determinants. CONSENSUS II Multi-Echo Study Group.
    Edner M; Bonarjee VV; Nilsen DW; Berning J; Carstensen S; Caidahl K
    Clin Cardiol; 1996 Jul; 19(7):543-8. PubMed ID: 8818434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on exercise performance of enalapril therapy initiated early after myocardial infarction. Nordic Enalapril exercise Trial.
    Dickstein K; Aarsland T
    J Am Coll Cardiol; 1993 Oct; 22(4):975-83. PubMed ID: 8409072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I.
    Swedberg K; Kjekshus J; Snapinn S
    Eur Heart J; 1999 Jan; 20(2):136-9. PubMed ID: 10099910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure.
    Coats AJ; Adamopoulos S
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):685-92. PubMed ID: 7873465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of early enalapril treatment on global and regional wall motion in acute myocardial infarction. CONSENSUS II Multi Echo Study Group.
    Carstensen S; Bonarjee VV; Berning J; Edner M; Nilsen DW; Caidahl K
    Am Heart J; 1995 Jun; 129(6):1101-8. PubMed ID: 7754939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential proischemic effect of early enalapril in hypotension-prone patients with acute myocardial infarction. The CONSENSUS II Holter Substudy Group.
    Søgaard P; Thygesen K
    Cardiology; 1997; 88(3):285-91. PubMed ID: 9129851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
    Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
    J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
    Swedberg K; Kjekshus J
    Am J Cardiol; 1988 Jul; 62(2):60A-66A. PubMed ID: 2839019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.